Patient reported changes in metabolic health during lockdown: A cross sectional digital connect survey in people with type 2 diabetes.

• Individuals reporting Self-Monitoring of Blood Glucose more than 140 mg/dl reduced to 18% during lockdown from 32.6%. • There were 81% and 74% increase in people who were unable to SMBG for fasting and post prandial glucose, respectively.

Single-pill Combination of Empagliflozin and Linagliptin in Real World Indian Type 2 Diabetes Patient (GRID).

Introduction: For the recently introduced single-pill combination of empagliflozin and linagliptin, real-world evidence has not been available. This observational study aims to assess real-world effectiveness of this combination, in the Indian outpatient setting of type-2 diabetes.

Methods: This was a prospective cohort study design, involving patients from 4 centres across western India.